Russian Journal of Bioorganic Chemistry · 2009 · 11 citations · 22 references
MedicineOncologyPharmacokineticsCancer PharmacologyMolecular OncologyPharmacokinetics Of Anticancer DrugsExperimental StudiesFluorine-18 ChemistryTyrosine Metabolism
Tyrosine derivatives labeled with a short-living fluorine 18 isotope (T(1/2) 110 min), namely 2-[(18)F]fluoro-L-tyrosine (FTYR) and O-(2'-[(18)F]fluoroethyl)-L-tyrosine (FET), promising radiopharmaceutical products (RPP) for positron emission tomography (PET), were obtained by asymmetric synthesis. Accumulation of FTYR and FET in the rat tumor "35 rat glioma" and in abscesses induced in Vistar mouse muscles was studied and compared with that of a well-known glycolysis radiotracer 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG). It was shown that the relative accumulation indices of amino acid RPP were considerably lower than those of FDG. At the same time, tumor/muscle ratios were high enough (2.9 for FET and 3.9 for FTYR 120 min after injection) for reliable tumor visualization. The data obtained indicated a possibility in principle to use FTYR and FET for differentiated PET diagnostics of brain tumors and inflammation lesions. Of the tyrosine derivatives studied, FET seems to be the most promising agent due to a simple and easily automated method of preparation based on direct nucleophilic substitution of the leaving tosyloxy group of an enantiomerically pure Ni-(S)-BPB-(S)-Tyr(CH2CH2OTs) precursor by an activated [(18)F]fluoride.
22
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Hans Wester, Michael Herz, Wolfgang Weber et al. · PubMed · 1999 · 466 citations
Wolfgang Weber, H.-J. Wester, Michael Herz et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2000 · 389 citations
Medicine, Oncology, Pharmacology +12
Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
Aren van Waarde, D. Cobben, Albert J.H. Suurmeijer et al. · PubMed · 2004 · 267 citations · Full text
Medicine, Nuclear Medicine, Oncology +17